GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil
01 Apr 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil
17 Mar 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil
25 Feb 2025 //
PR NEWSWIRE
GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil
09 Dec 2024 //
PR NEWSWIRE
GRIN Therapeutics Reports Positive Radiprodil Data In GRIN-Related Disorder
09 Sep 2024 //
PR NEWSWIRE
Grin Announces First Patient Dosed in Phase 1B Clinical Trial with Radiprodil
23 Mar 2023 //
BUSINESSWIRE